Atossa Therapeutics, Inc.
ATOS • NASDAQ • Stock Fundamentals
Atossa Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Steven C. Quay, with a market cap of $45.0M.
Market Cap$45.0M
Employees10.0
CEOSteven C. Quay
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 8, 2026 · 1 month 4 days agoQ1 2026
View reportNext EarningsAug 11, 2026 · in 2 monthsQ2 2026
Financials
Based on Q1 2026 filing
Atossa Therapeutics, Inc. FAQ
Common questions about Atossa Therapeutics, Inc.
Atossa Therapeutics, Inc. (ATOS) has a market capitalization of $45.0M and trades on NASDAQ.
Atossa Therapeutics, Inc. has approximately 10 employees.